Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cance (Q36750960)
Jump to navigation
Jump to search
scientific article published on 3 January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cance |
scientific article published on 3 January 2013 |
Statements
1 reference
Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cance (English)
1 reference
Jerome C Landry
1 reference
Yang Feng
1 reference
Steven J Cohen
1 reference
Charles A Staley
1 reference
Richard Whittington
1 reference
Elin Ruth Sigurdson
1 reference
Halla Nimeiri
1 reference
Udit Verma
1 reference
Roshan S Prabhu
1 reference
Al Bowen Benson
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference